|
|
||||||||
Journal of Lipid Research, Vol 33, 1193-1200, Copyright © 1992 by Lipid Research, Inc.
ARTICLES |
S Shefer, LB Nguyen, G Salen, GC Ness, IR Chowdhary, S Lerner, AK Batta and GS Tint
Department of Medicine, University of Medicine and Dentistry of New Jersey-New Jersey Medical School, Newark 07103.
We investigated the effects of cholesterol, cholestyramine, and taurocholate feeding on steady state specific activities and mRNA levels of hepatic 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase and cholesterol 7 alpha-hydroxylase in the rat. Interruption of the enterohepatic circulation of bile acids (cholestyramine feeding) increased total HMG-CoA reductase activity 5-fold. Cholesterol and taurocholate administration suppressed total microsomal HMG-CoA reductase activities 87% and 65%, respectively. HMG-CoA reductase mRNA levels increased 3-fold with cholestyramine, did not decrease significantly with cholesterol feeding, but were markedly decreased after taurocholate treatment. Cholesterol 7 alpha-hydroxylase activity increased 4-fold with cholestyramine and 29% during cholesterol feeding, but decreased 64% with taurocholate. Cholesterol 7 alpha- hydroxylase mRNA levels rose 150% and 50% with cholestyramine and cholesterol feeding, respectively, but decreased 73% with taurocholate. The administration of cholesterol together with taurocholate prevented the decline in cholesterol 7 alpha-hydroxylase mRNA levels, but inhibition of enzyme activity persisted (-76%). Hepatic microsomal cholesterol concentrations increased 2-fold with cholesterol feeding but did not change with taurocholate or cholestyramine treatment. These results demonstrate that mRNA levels of HMG-CoA reductase are controlled by the hepatic taurocholate flux, whereas mRNA levels of cholesterol 7 alpha-hydroxylase are controlled by the cholesterol substrate supply. These end products, cholesterol and bile acids, exert post-transcriptional regulation on HMG-CoA reductase and cholesterol 7 alpha-hydroxylase, respectively.
This article has been cited by other articles:
![]() |
Q. Shang, L. Pan, M. Saumoy, J. Y. L. Chiang, G. S. Tint, G. Salen, and G. Xu An overlapping binding site in the CYP7A1 promoter allows activation of FXR to override the stimulation by LXR{alpha} Am J Physiol Gastrointest Liver Physiol, October 1, 2007; 293(4): G817 - G823. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Shang, L. Pan, M. Saumoy, J. Y. L. Chiang, G. S. Tint, G. Salen, and G. Xu The stimulatory effect of LXR{alpha} is blocked by SHP despite the presence of a LXR{alpha} binding site in the rabbit CYP7A1 promoter J. Lipid Res., May 1, 2006; 47(5): 997 - 1004. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. T. Cramer, B. Goetz, K. L. M. Hopson, G. J. Fici, R. M. Ackermann, S. C. Brown, C. L. Bisgaier, W. G. Rajeswaran, D. C. Oniciu, and M. E. Pape Effects of a novel dual lipid synthesis inhibitor and its potential utility in treating dyslipidemia and metabolic syndrome J. Lipid Res., July 1, 2004; 45(7): 1289 - 1301. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Xu, L.-x. Pan, H. Li, Q. Shang, A. Honda, S. Shefer, J. Bollineni, Y. Matsuzaki, G. S. Tint, and G. Salen Dietary cholesterol stimulates CYP7A1 in rats because farnesoid X receptor is not activated Am J Physiol Gastrointest Liver Physiol, May 1, 2004; 286(5): G730 - G735. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Xu, H. Li, L.-x. Pan, Q. Shang, A. Honda, M. Ananthanarayanan, S. K. Erickson, B. L. Shneider, S. Shefer, J. Bollineni, et al. FXR-mediated down-regulation of CYP7A1 dominates LXR{alpha} in long-term cholesterol-fed NZW rabbits J. Lipid Res., October 1, 2003; 44(10): 1956 - 1962. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Davis, J. H. Miyake, T. Y. Hui, and N. J. Spann Regulation of cholesterol-7{alpha}-hydroxylase: BAREly missing a SHP J. Lipid Res., April 1, 2002; 43(4): 533 - 543. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Xu, G. Salen, B. L. Shneider, M. Ananthanarayanan, S. Shefer, L. Ma, A. Batta, L. B. Nguyen, J. J. Lingutla, G. S. Tint, et al. Cholecystectomy prevents expansion of the bile acid pool and inhibition of cholesterol 7{alpha}-hydroxylase in rabbits fed cholesterol J. Lipid Res., September 1, 2001; 42(9): 1438 - 1443. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. C. Ness and C. M. Chambers Feedback and Hormonal Regulation of Hepatic 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase: The Concept of Cholesterol Buffering Capacity Experimental Biology and Medicine, May 1, 2000; 224(1): 8 - 19. [Abstract] [Full Text] |
||||
![]() |
G. Xu, B. L. Shneider, S. Shefer, L. B. Nguyen, A. K. Batta, G. S. Tint, M. Arrese, S. Thevananther, L. Ma, S. Stengelin, et al. Ileal bile acid transport regulates bile acid pool, synthesis, and plasma cholesterol levels differently in cholesterol-fed rats and rabbits J. Lipid Res., February 1, 2000; 41(2): 298 - 304. [Abstract] [Full Text] |
||||
![]() |
A. Honda, G. Salen, S. Shefer, A. K. Batta, M. Honda, G. Xu, G. S. Tint, Y. Matsuzaki, J. Shoda, and N. Tanaka Bile acid synthesis in the Smith-Lemli-Opitz syndrome: effects of dehydrocholesterols on cholesterol 7{alpha}-hydroxylase and 27-hydroxylase activities in rat liver J. Lipid Res., August 1, 1999; 40(8): 1520 - 1528. [Abstract] [Full Text] |
||||
![]() |
M. L. Fernandez, T. A. Wilson, K. Conde, M. Vergara-Jimenez, and R. J. Nicolosi Hamsters and Guinea Pigs Differ in Their Plasma Lipoprotein Cholesterol Distribution when Fed Diets Varying in Animal Protein, Soluble Fiber, or Cholesterol Content J. Nutr., July 1, 1999; 129(7): 1323 - 1332. [Abstract] [Full Text] |
||||
![]() |
G. Xu, G. Salen, S. Shefer, G. S. Tint, L. B. Nguyen, T. T. Parker, T. S. Chen, J. Roberts, X. Kong, and D. Greenblatt Regulation of classic and alternative bile acid synthesis in hypercholesterolemic rabbits: effects of cholesterol feeding and bile acid depletion J. Lipid Res., August 1, 1998; 39(8): 1608 - 1615. [Abstract] [Full Text] |
||||
![]() |
K. K. Buhman, E. J. Furumoto, S. S. Donkin, and J. A. Story Dietary Psyllium Increases Fecal Bile Acid Excretion, Total Steroid Excretion and Bile Acid Biosynthesis in Rats J. Nutr., July 1, 1998; 128(7): 1199 - 1203. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. V. Rodrigueza, K. D. Mazany, A. D. Essenburg, M. E. Pape, T. J. Rea, C. L. Bisgaier, and K. J. Williams Large Versus Small Unilamellar Vesicles Mediate Reverse Cholesterol Transport In Vivo Into Two Distinct Hepatic Metabolic Pools : Implications for the Treatment of Atherosclerosis Arterioscler. Thromb. Vasc. Biol., October 1, 1997; 17(10): 2132 - 2139. [Abstract] [Full Text] |
||||
![]() |
G S. Tint, M. Irons, E. R. Elias, A. K. Batta, R. Frieden, T. S. Chen, and G. Salen Defective Cholesterol Biosynthesis Associated with the Smith-Lemli-Opitz Syndrome N. Engl. J. Med., January 13, 1994; 330(2): 107 - 113. [Abstract] [Full Text] |
||||
![]() |
D. M. Baker, S.-L. Wang, D. J. Bell, C. A. Drevon, and R. A. Davis One or More Labile Proteins Regulate the Stability of Chimeric mRNAs Containing the 3'-Untranslated Region of Cholesterol-7alpha -hydroxylase mRNA J. Biol. Chem., June 23, 2000; 275(26): 19985 - 19991. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |